U
AUXL

UBS’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

UBS’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$230K Buy
7,700
+3,700
+93% +$78.4K ﹤0.01% 5058
2014
Q2 		$80K Hold
4,000
– – ﹤0.01% 6235
2014
Q1 		$109K Sell
4,000
-2,400
-38% -$63.7K ﹤0.01% 5879
2013
Q4 		$133K Sell
6,400
-900
-12% -$17K ﹤0.01% 5745
2013
Q3 		$133K Buy
7,300
+6,800
+1,360% +$123K ﹤0.01% 5689
2013
Q2 		$8K Buy
+500
New +$7.99K ﹤0.01% 8933

Other funds holding AUXL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

UBS's AUXL Position: Q3 2014 in Review

UBS reduced its AUXILIUM PHARAMCEUTICALS INC (AUXL) stake by 61% in Q3 2014, selling an estimated $8.37M and leaving 255,366 shares worth $7.62M. The position accounts for 0.01% of the portfolio, ranked #1670.

UBS first reported a position in AUXL in Q2 2013 and has held it in 6 quarters since. The position peaked at $13.6M in Q1 2014. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2014.

  • UBS held 255,366 shares of AUXILIUM PHARAMCEUTICALS INC worth $7.62M as of Q3 2014.
  • UBS sold 394,697 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2014, an estimated $8.37M.
  • AUXILIUM PHARAMCEUTICALS INC made up 0.01% of UBS's portfolio in Q3 2014, its #1670 holding.
  • UBS first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and has held it in 6 quarters since.
  • UBS's AUXILIUM PHARAMCEUTICALS INC position peaked at $13.6M in Q1 2014.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.